← Open Payments lookup

CHRISTOPHER BENNETT: Open Payments

NPI 1437475134 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,173 in 97 payments from 17 companies in 2025. Trend: 2023 $598 · 2024 $1,240 · 2025 $2,173

Food & beverage: $2,173
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$325
E.R. Squibb & Sons, L.L.C.11$284
ABBVIE INC.15$283
Teva Pharmaceuticals USA, Inc.10$202
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$179
Alkermes, Inc.8$160
Axsome Therapeutics, Inc.3$146
Corium, LLC5$129
Otsuka America Pharmaceutical, Inc.5$109
Tris Pharma Inc3$68

Products named: INGREZZA, COBENFY, VRAYLAR, CAPLYTA, ARISTADA, Auvelity, UZEDY, Azstarys.

Industry payments across MD — which companies pay providers there.